These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 2764528)

  • 1. Comparative in vitro antibiotic resistance of surface-colonizing coagulase-negative staphylococci.
    Gristina AG; Jennings RA; Naylor PT; Myrvik QN; Webb LX
    Antimicrob Agents Chemother; 1989 Jun; 33(6):813-6. PubMed ID: 2764528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotic resistance of biomaterial-adherent coagulase-negative and coagulase-positive staphylococci.
    Naylor PT; Myrvik QN; Gristina A
    Clin Orthop Relat Res; 1990 Dec; (261):126-33. PubMed ID: 2173986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibiotic susceptibility of coagulase-negative staphylococcal blood isolates with special reference to adherent, slime-producing Staphylococcus epidermidis strains.
    Kotilainen P; Nikoskelainen J; Huovinen P
    Scand J Infect Dis; 1991; 23(3):325-32. PubMed ID: 1882198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-vitro induction of resistance in coagulase-negative staphylococci to vancomycin and teicoplanin.
    Watanakunakorn C
    J Antimicrob Chemother; 1988 Sep; 22(3):321-4. PubMed ID: 2972670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro susceptibilities of four species of coagulase-negative staphylococci.
    Fass RJ; Helsel VL; Barnishan J; Ayers LW
    Antimicrob Agents Chemother; 1986 Oct; 30(4):545-52. PubMed ID: 3539009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro inhibition of coagulase-negative staphylococci by vancomycin/aminoglycoside-loaded cement spacers.
    Streuli JC; Exner GU; Reize CL; Merkofer C; Scott CP; Zbinden R
    Infection; 2006 Apr; 34(2):81-6. PubMed ID: 16703297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of LY146032 and vancomycin against coagulase-negative staphylococci.
    Low DE; Poon R
    Eur J Clin Microbiol; 1987 Apr; 6(2):190. PubMed ID: 3595581
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition of Staphylococcus adherence to biomaterials by extracellular slime of S. epidermidis RP12.
    Giridhar G; Kreger AS; Myrvik QN; Gristina AG
    J Biomed Mater Res; 1994 Nov; 28(11):1289-94. PubMed ID: 7829558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity of daptomycin against enterococci and coagulase-negative staphylococci (CNS): relationship between CNS susceptibility and slime production.
    Marone P; Perversi L; Navarra A; Monzillo V; Sartirana E
    J Chemother; 1993 Jun; 5(3):151-4. PubMed ID: 8396625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of bacterial adherence to intravascular catheters on in-vitro antibiotic susceptibility.
    Sheth NK; Franson TR; Sohnle PG
    Lancet; 1985 Dec; 2(8467):1266-8. PubMed ID: 2866335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microbiologic studies of coagulase-negative staphylococci isolated from patients with nosocomial bacteraemias.
    Ponce de Leon S; Guenthner SH; Wenzel RP
    J Hosp Infect; 1986 Mar; 7(2):121-9. PubMed ID: 2871074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coagulase-negative staphylococci in air samples from operating theatres.
    Kiss L; Sztroj T; Széll M
    Acta Microbiol Immunol Hung; 1996; 43(1):39-46. PubMed ID: 8806942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro selection of bacteria resistant to LY146032, a new cyclic lipopeptide.
    Liebowitz LD; Saunders J; Chalkley LJ; Koornhof HJ
    Antimicrob Agents Chemother; 1988 Jan; 32(1):24-6. PubMed ID: 2831813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative in vitro activities of new fluorinated quinolones and other antibiotics against coagulase-negative Staphylococcus blood isolates from neutropenic patients, and relationship between susceptibility and slime production.
    Venditti M; Santini C; Serra P; Micozzi A; Gentile G; Martino P
    Antimicrob Agents Chemother; 1989 Feb; 33(2):209-11. PubMed ID: 2719465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased oxacillin activity associated with glycopeptides in coagulase-negative staphylococci.
    Domaracki BE; Evans A; Preston KE; Fraimow H; Venezia RA
    Eur J Clin Microbiol Infect Dis; 1998 Mar; 17(3):143-50. PubMed ID: 9665294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study of coagulase-negative staphylococci with reference to slime production, adherence, antibiotic resistance patterns and clinical significance.
    Jones JW; Scott RJ; Morgan J; Pether JV
    J Hosp Infect; 1992 Nov; 22(3):217-27. PubMed ID: 1362739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Correlation of slime production and pathogenicity of coagulase-negative staphylococci].
    Végh Z; Gacs M
    Orv Hetil; 1990 Feb; 131(5):231-4. PubMed ID: 2406682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between slime production, antibiotic sensitivity and the phagetype of coagulase-negative staphylococci.
    Boussard P; Pithsy A; Devleeschouwer MJ
    J Clin Pharm Ther; 1993 Aug; 18(4):271-4. PubMed ID: 8227235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial resistance of coagulase-negative staphylococci from a Kuwait hospital.
    Udo EE; Jacob LE; Chugh TD
    Microb Drug Resist; 1995; 1(4):315-20. PubMed ID: 9158802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bactericidal action of nafcillin, vancomycin, and three cephalosporins against nafcillin-susceptible and nafcillin-resistant coagulase-negative staphylococci.
    Mordenti JJ; Davis RH; Lammel CJ; Brooks GF
    Diagn Microbiol Infect Dis; 1986 May; 5(1):1-8. PubMed ID: 3635453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.